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Abstract
Fatty acids are known to play a key role in promoting
the loss of insulin sensitivity causing insulin resistance
and type 2 diabetes. However, underlying mechanism
involved here is still unclear. Incubation of rat skeletal
muscle cells with palmitate followed by I125- insulin
binding to the plasma membrane receptor preparation
demonstrated a two-fold decrease in receptor
occupation. In searching the cause for this reduction,
we found that palmitate inhibition of insulin receptor
(IR) gene expression effecting reduced amount of IR
protein in skeletal muscle cells. This was followed by
the inhibition of insulin-stimulated IRβ tyrosine
phosphorylation that consequently resulted inhibition
of insulin receptor substrate 1 (IRS 1) and IRS 1
associated phosphatidylinositol-3 kinase (PI3 Kinase),
phosphoinositide dependent kinase-1 (PDK 1)
phosphorylation. PDK 1 dependent phosphorylation
of PKCζ and Akt/PKB were also inhibited by palmitate.
Surprisingly, although PKCε phosphorylation is PDK1
dependent, palmitate effected its constitutive
phosphorylation independent of PDK1. Time kinetics
study showed translocation of palmitate induced
phosphorylated PKCε from cell membrane to nuclear
region and its possible association with the inhibition
of IR gene transcription. Our study suggests one of
the pathways through which fatty acid can induce
insulin resistance in skeletal muscle cell.
Introduction
Insulin resistance and type 2 diabetes mellitus is an
insidious disease that accounts for more than 95% of
diabetic cases. This heterogeneous disorder is increasing
in epidemic proportions; its worldwide frequency is
expected to grow more than 6% per annum [1, 2]. The
disease is primarily expressed in the form of
hyperglycemia due to defects in glucose disposal into
skeletal muscle, fat and liver as they become less
responsive or resistant to insulin [3, 4]. Large number of
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evidences has been accumulated that hold fatty acids
responsible for the loss of insulin sensitivity. Elevated fatty
acid in circulation are associated with impaired insulin
function and is commonly linked with obesity and type 2
diabetes [5-7]. Lowering of elevated plasma fatty acids
levels normalized insulin sensitivity in diabetic subjects
[8]. Incubation of isolated muscle strips or cultured muscle
cells with fatty acids reduces insulin stimulated glucose
uptake [6, 7, 9-11]. These reports suggest that greater
deposition of lipid in insulin sensitive tissues promotes loss
of its activity and insulin resistance.
How insulin loses its sensitivity and fails to act in the
presence of elevated fatty acids is yet unclear. It has
been observed that lowering of glucose transport by fatty
acid is associated with the inhibition of insulin stimulated
IRS1 and IRS1 associated PI3K phosphorylation [12, 13]
that affects downstream effectors such as Akt and Glut4
[14-17]. All these suggest that impairment of insulin
activity is linked to insulin signaling defects. Insulin signaling
molecules that are involved in the metabolic and mitogenic
actions of insulin have also been suggested to play a role
in cellular insulin resistance [18-20]. Protein kinase C
(PKC) isoforms represents such signaling molecules.
PKC isoforms are classified as classical (cPKCα, βΙ,
βΙΙ, γ), novel (nPKC δ,ε,θ,η) and atypical (aPKC ζ,τ/λ).
cPKCs are activated by Ca2+  and diacylglycerol (DAG),
nPKCs are activated by DAG only and aPKCs respond
to neither Ca2+ nor DAG [21]. A few PKC isoforms are
indicated to have regulatory role on insulin signaling.
Expression levels and activities of some of the PKC
isoforms are found to be associated with insulin resistance
in type 2 diabetic patients, animal models of diabetes and
different types of cell models [22-24]. Recent reports
indicate a link between PKC and fatty acid-induced insulin
resistance. Lipid infusion in rats and humans impaired
insulin-stimulated glucose disposal in muscles and
concomitant activation of certain PKC isoforms [11, 13,
25]. However, the mechanism underlying insulin-signaling
defects due to fatty acid is not yet clear. In this
communication we report impairment of insulin binding
to insulin receptor (IR) in skeletal muscle cells by fatty
acid that consequently reduced IRβ tyrosine
phosphorylation and insulin induced downstream signals.
In searching the cause for this impairment, we have found
an inhibition of IR gene expression and an association of
PKC ε with IR gene downregulation.
Materials and Methods
Materials
All tissue culture materials were obtained from Gibco-
BRL, Life Technologies Inc., Gaithersburg, MD 20884-9980,
USA. Palmitate, trypsin, porcine insulin was purchased from
Sigma chemical company, St Louis, MO, USA. 2-deoxy- [1-3H]
glucose (Specific activity: 12.0 Ci/mmol) was from Amersham
Biosciences, USA. Calphostin C was from Biomol Research
Labs Inc. (Plymouth Meeting, PA). Antibodies utilized included
anti IR-β (anti-rabbit), anti-p-Tyr (anti-mouse, PY99) anti-p-IRS
1 (anti-goat, Tyr 632), anti-p-PI3K (anti-goat, Tyr 508), anti
pPDK1 (anti rabbit), anti-p-Akt 1/2/3 (anti-rabbit, Ser 473), anti-
p-PKC ε (anti-goat), anti-p-PKC ζ (anti-rabbit), anti-p-PKC δ
(anti-rabbit) and antibodies against IRS1, PI3 K, Akt1/2, PKC ε
were from Santa Cruz Biotechnology Inc., USA. Anti PDK1
(anti rabbit) was purchased from Cell Signaling Technologies,
USA. Alkaline phosphatase or horse-radish peroxidase
conjugated anti-rabbit, and anti-goat secondary antibodies were
also purchased from Santa Cruz Biotechnology Inc., USA. All
other chemicals were from Sigma Chemical Co. USA.
Cell Culture and treatments
All animals were handled in accordance with the Animal
ethics committee, IICB, India. Soleus muscles from 2-3 day old
neonatal Sprague-Dawley rats were dissected out and
separated in a biological safety cabinet by following the method
mentioned by Dennis et al [26] with some modifications. Briefly,
soleus muscle strips were incubated in 0.2% collagenase and
0.05% trypsin in PBS (phosphate buffered saline 0.05M, pH
7.5, 0.15M NaCl) with continuous stirring. The dispersed skeletal
muscle cells were pelleted by centrifugation at 500g, washed
and resuspended in Kreb’s Henseleit buffer (KHB) containing
10% fetal calf serum and 1% penicillin/streptomycin. Skeletal
muscle cells were preincubated in glucose-free KHB at 37°C
under 95% O2/5% CO2 for 1hr. Muscle cells were then seeded
to collagen-coated dish containing Dulbecco’s Modified
Eagle’s Medium (DMEM). For primary culture, beginning at 48
h of cell plating, the medium was replaced every 48h till the
cells become confluent, which required 3-8 days. On attaining
the confluence, cells were incubated in the absence (control)
or presence of 0.75 mM palmitate (Lipid-containing media were
prepared by conjugation of  fatty acid with -free bovine serum
albumin, by a method modified from the method described by
Chavez et al. [35], with or without 100nM insulin at the time
periods mentioned under different experiments.  In the case of
experiments with calphostin C (a strong inhibitor of protein
kinase C), cells were preincubated for 30 min in 100nM
calphostin C prior to incubation with fatty acid.
Radiolabeled insulin binding to solubilized receptor
preparations
Membrane preparation from skeletal muscle and binding
experiments were carried out by following the method
previously described by us [27] with a little modification. Briefly,
control and palmitate treated skeletal muscle cells were washed
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thrice with 0.02M Phosphate Buffer (pH-7.4) containing 0.14M
NaCl and resuspended in Lysis buffer [20mM Tris-HCl, 40mM
NaCl, 5mM EDTA, 5mM Iodoacetamide, 0.1% Triton X100, pH-
8.4, supplemented with protease inhibitors (1µg/ml aprotinin,
1µg/ml pepstatin, 1µg/ml leupeptin, 2mM phenyl methyl sulfonyl
fluoride and 1µg/ml soybean trypsin inhibitor)], sonicated and
centrifuged at 10,000 g for 15min at 4°C. The lipid-laden part of
the supernatant phase was removed; supernatant was then
layered on the top of a sucrose gradient formed by 50, 40, 36,
and 30% sucrose (from bottom to top). Tubes were centrifuged
at 60,000g in a (Sorvall Ultra-80) ultracentrifuge for 90min and
the membrane fraction was obtained between 35 and 40%
sucrose gradient, dialyzed overnight against 0.02M phosphate
buffer (pH-8.4) and volume reduced by lyophilization. The
membrane fraction was mixed with 0.1M lithium diiodosalicylate
and to this solution 0.1% TritonX-100 (v/v) and 25% glycerol
was added with constant stirring. The solution was dialyzed
against 0.02M-phosphate buffer (pH 8.4), lyophilized to reduce
the volume and used as solubilized membrane preparation.
Recombinant human insulin was radiolabelled with 125I and
separated from free 125I through Sephadex-G15 column
equilibrated with 0.01M Phosphate Buffer (pH-7.2) containing
0.14M NaCl and 1% (w/v) BSA. Specific activity of 125I-insulin
was 30.55µCi/µg of protein.
For the preparation of solubilized receptors covalently
labeled with 125I-insulin, their separation through SDS-PAGE
and autoradiography, we followed the method described by
Velicelebi and Aiyer [28] with little modification. Briefly,
solubilized membrane preparation from control or palmitate
treated skeletal muscle cells (25µg from each incubation) was
incubated overnight at 4°C with 2ng 125I-Insulin in a final volume
of 500µl of 0.02M phosphate buffer (pH-8.4) containing 0.15M
NaCl and 0.25% BSA. On termination of incubation, it was
pelleted by ultracentrifugation (Sorvall Ultra-80) at 105 g for
1hour. Pellet in each tube was dissolved in 1x sample buffer
(63mM Tris HCl pH 6.8, 10% glycerol, 2% SDS, and 0.025%
Bromophenol blue) and subjected to non-reducing SDS-PAGE
(4% stacking gel was layered on the top of a 7.5% resolving
gel) with prestained high molecular weight protein marker (MBI
Fermentas, USA). The gel was dried, exposed to Kodak X-
OMAT AR for 24 h and developed.
Determination of specific binding and Scatchard
analysis
Cells were incubated with or without palmitate for 8h,
lysed and membranes were prepared according to the above
description. To determine the optimum binding conditions of
125I-Insulin to the receptor protein, binding incubations were
performed at different temperatures and time intervals with
varied amount of solubilized receptor preparations. It was found
that overnight incubation of 15 µg of solubilized membrane
protein at pH 8.4 and a temperature of 4°C permitted optimum
radiolabeled insulin binding. Solubilized membrane preparations
(15 µg protein) from control or palmitate treated cells were
incubated overnight at 4°C in a final volume of 500 µl buffer
(0.02M phosphate buffer, pH 8.4, containing 0.15M NaCl and
0.25% BSA) with varying concentrations of 125I-Insulin (0.18-
0.72 nmoles/L) in the absence (total binding) or presence of
10,000 fold excess unlabeled insulin (specific binding). On
termination of the incubations, free and bound radioactivity
was separated by adding 500 µl of 0.5% chilled polyethylene
glycol (PEG; MW 6000) followed by centrifugation at 20,000g
in a refrigerated centrifuge for 15 min. The supernatant was
aspirated out and the pellet was washed thrice with washing
buffer (0.02M phosphate buffer of pH 8.4 containing 0.15M
NaCl and 0.25% BSA). The radioactivity in the final pellet was
measured in a gamma counter. The specific binding was
calculated by using the formula B-bo/Bo-bo X 100 where B
corresponds to the binding in the presence of cold (unlabelled
insulin), bo represents non-specific binding, and Bo was the
binding in the absence of cold. Data were then subjected to
Scatchard analysis to determine the affinity and capacity of
insulin binding to the receptor.
Reverse transcription PCR and Northern blotting
Total RNA was extracted from control and treated skeletal
muscle cells using Tri-reagent (Sigma-Aldrich). 2.5 micrograms
of total RNA was reverse transcribed with MuL-V-reverse
transcriptase (MBI Fermentas, Vilinius, Lithuania) primed with
deoxythymidine 5’-GGAAGCTTTTTTTTTTTTTTT-3’ oligos.
Reaction was carried out in 20µl total volume containing 10µM
dithiotreitol (DTT), 0.5mM of each deoxynucleotide
triphosphate, 50mM Tris-HCl (pH 8.3), 75mM KCl, and 3mM
MgCl2 for 1h at 42°C. Two microlitres of first strand cDNA was
amplified in 50µl PCR reaction mixture containing 2.5 U Taq
Polymerase (Advantage2 RT-PCR kit, BD Biosciences, Palo Alto,
CA); 1.5mM MgCl2; and 200µM each of deoxyNTP (Sigma -
Aldrich) and the buffer supplied with the enzyme along with
2µl each of sense and antisense primers diluted to 10µM.
Following primers were designed –
IR sense, 5’-GGATGGTCAGTGTGTGGAGA-3’
antisense, 5’-TCGTGAGGTTGTGCTTGTTC-3’;
β actin sense,
5’-TGACGGGGTCACCCACACTGTGCCCATCTA-3’
antisense,
5’-CTAGAAGCATTTGCGGTGGACGATGGAGGG-3’.
Insulin receptor sequence from Rattus norvegicus
(GeneID: 24954) was chosen for designing the primers for insulin
receptor gene, and amplifying approximately 165 bp segment
of rat insulin receptor homologue. The PCR was performed for
30 cycles of denaturation at 94°C, for 45sec(5 min in the first
cycle), annealing at 55°C for 30sec, and extension at 72°C for 1
min (10 min last cycle; Perkin Elmer 9700; PE Applied
Biosystems, Foster City, CA) with a manual hotstart protocol.
A house keeping gene β actin was amplified simultaneously to
serve as an internal control. The PCR product of insulin receptor
was cloned into pTZ57R/T plasmid using InsTA clone PCR
cloning kit (MBI Fermentas) following the manufacturers
instruction and sequenced using ABI PRISM 3100 (Perkin Elmer
PE, Applied Biosystems) automated sequencer. Sequence
analysis was done by BLAST software available on the NCBI
Website.
Role of PKC Isoforms in Insulin Signaling Impairment Cell Physiol Biochem 2005;16:217-228
220
RNA was isolated from skeletal muscle cells using the Tri
reagent RNA extraction kit (Sigma Chemical Co., USA) following
manufacturer’s instructions. 10 µg of total RNA were loaded
on each lane of a 1% formaldehyde-agarose gel electrophoresed
and transferred to a PVDF membrane. The membrane was
hybridized with XbaI-BamHI fragment of rat insulin receptor
cDNA cloned in TA cloning vector. Prehybridisation was allowed
for 4h in the buffer containing 6x SSC with 80% formaldehyde,
1x Denhardt’s solution and 0.5% SDS at 42°C. Hybridization
was carried out under similar conditions with γp32-labelled rat
insulin receptor cDNA for 12h. The membrane was washed for
90min at 65°C in 2x SSC containing 0.1% SDS with subsequent
three changes of buffer. The hybridized membrane was exposed
to Kodak X-ray film for 24h (Eastman Kodak Company,
Rochester, NY) at 80°C. The digestion of DNA, agarose gel
electrophoresis, DNA random labeling and Northern
hybridization were performed according to the method
described by Sambrook et al.
Electrophoresis and Immunoblotting
Cell pellets from control and treated incubations were
suspended in lysis buffer (1% NP-40, 20 mM HEPES (pH 7.4), 2
mM EDTA, 100 mM NaF, 10 mM sodium pyrophosphate, 1 mM
sodium orthovanadate, 1 µg/ml leupeptin, 1 µg/ml aprotinin,
1 µg/ml pepstatin and 1 mM PMSF) and sonicated on ice at 150
KHz for 5 min. Lysates were centrifuged for 10 min at 10,000g,
supernatant was collected and protein content was estimated
according to Lowry et al [29]. Control and treated cell lysates
(50 µg) were resolved on 10% SDS-PAGE and transferred to
PVDF membranes (Millipore, Bedford, MA 01730) through
transfer buffer (25 mM Tris, 193 mM glycine, 20 % methanol,
pH 8.5) for 1.5 h. Electrophoresis was carried out at 90V constant
voltage. Membranes were incubated with 5% Blocking buffer
(20mM Tris base, 137mM NaCl, 1mM HCl, 0.1% Tween 20 and
5% non-fat milk) for 1h followed by incubation with primary
antibodies such as anti insulin receptor β (IRβ), anti p-IRS 1
(anti-goat; 1:1000), anti p-PI3K (anti-goat; 1:1000) and anti p-
Akt 1/2/3 (anti-rabbit; 1:1000), anti-p-PKC ε (anti-goat), anti-p-
PKC ζ (anti-rabbit), anti-p-PKC δ (anti-rabbit) antibodies,
overnight at 4°C. A concurrently run gel was immunoblotted
with anti IRS 1(anti-goat; 1:1000), anti PI3K (anti-goat; 1:1000),
anti PDK1 (anti rabbit;1:1000), anti PKC ε (anti goat; 1:1000)
and anti Akt 1/2 (anti-rabbit; 1:1000) antibodies. Bound primary
antibodies were visualized using corresponding secondary
antibodies at 1:1000 dilution, which were tagged either with
alkaline phosphatase or horse-radish peroxidase and were
developed with corresponding substrates nitro blue tetrazolium
/ 5-bromo 4-chloro 3-indolyl phosphate or tetramethyl
benzidene / H2O2 respectively.
Immunoprecipitation
To observe insulin receptor β tyrosine phosphorylation,
control and palmitate treated skeletal muscle cells were
incubated with insulin (100 nM) for 30 min, lysed by sonication
in lysis buffer (as described above) followed by centrifugation
at 10,000 g for 10 min. Supernatant was collected, and 200 µg of
protein was incubated overnight at 4°C with 2 µg insulin
receptor β (IR β) antibody. 50 µl of protein A-sepharose was
then added to each tube and incubated at 4°C for 2h followed
by centrifugation at 10,000g. Immune-complexed IR β was
resuspended in 500 µl of 0.1% CHAPS in PBS, washed
thoroughly and subjected to SDS-PAGE followed by
immunoblotting with anti-phosphotyrosine antibody (anti-
mouse; 1:1000).
Immunofluorescence staining
Skeletal muscle cells were seeded on sterile uncoated 22-
mm coverslips and grown for 2 days in DMEM with 10% fetal
bovine serum in a humidified atmosphere of 95% O2/ 5% CO2 at
37°C. Cells were serum starved for 10h and incubated with
palmitate (0.75mM) at different time periods, control incubation
contained BSA as vehicle. On termination of incubation, cells
were subjected to fixation with 3.5% paraformaldehyde in
Hanks’ salt solution containing 20 mM HEPES, pH 7.0,
permeabilized in phosphate-buffered saline containing 0.1%
Triton X-100 and 1% BSA for 5 min followed by incubation
with anti-PKCε antibody. After treatment with fluorescein
isothiocyanate (FITC)-conjugated secondary antibody (1:100),
coverslips were mounted in glycerol/PBS and viewed with
fluorescence microscope (Olympus, Tokyo, Japan).
Statistical analysis
Data were analyzed by one-way analysis of variance
(ANOVA) where the F value indicated significance, means were
compared by Duncun’s multiple range post hoc test. All values
were means ± SEM of three independent observations.
Results
Downregulation of IR and IR gene expression by
palmitate
Skeletal muscle cells were incubated in the absence
(control) or presence of palmitate for 8h. Plasma
membrane preparation from them was solubilized and
allowed to bind with radiolabelled insulin. Proteins were
then resolved through non-reducing PAGE followed by
autoradiography. Fig 1a shows that 125I was bound to
210 kDa protein which corroborated earlier reports on
detergent solubilized IR [28, 30, 31]. 125I-insulin binding
to IR was greatly reduced due to palmitate incubation. In
a separate experiment, membrane preparation from
control or palmitate-incubated skeletal muscle cells was
subjected to in-vitro binding incubation with 125I-insulin in
the presence or absence of unlabeled insulin. Palmitate
did not alter Ka but it effectively reduced Bmax from 7.3pM
to 3.46pM (Fig 1b). Unaltered Ka indicate that inhibition
by palmitate is not due to modulation of IR protein, it is
possibly for the reduction in IR number since Bmax gets
reduced. This led us to determine the expression of IR
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Fig. 1. Skeletal muscle cells were incubated for 8h without (C) or with
palmitate (P) and cell membrane preparation was solubilized with 0.1%
TritonX-100. 25 µg of solubilized membrane protein obtained from control
and palmitate treated cells was allowed to react with 2 ng 125I-insulin for
overnight at 4°C. On termination of incubation, it was pelleted by
ultracentrifugation at 105 g for 1 h, electrophoresed through SDS-PAGE
with marker proteins and autoradiographed (a). 125I-Insulin binding to cell
membrane receptor preparation in the absence (Control) or presence of
palmitate was observed with varying concentrations of 125I-Insulin (0.18-
0.72 nmoles/L) and a fixed concentration of 10,000 fold excess of unlabelled
insulin and 25 µg of membrane protein. Affinity and capacity of binding
was determined from Scatchard analysis (b). (Bsp: specific binding; F: free
counts).
Fig. 2. Expression patterns of IR gene was examined by semiquantitative RT-
PCR using RNA samples from vehicle (C) or palmitate treated (P) skeletal muscle
cells, β actin was used as an internal control (a). Determination of palmitate
induced reduction of IR gene expression by Northern blotting. 10 µg each of
total RNA from control and palmitate treated skeletal muscle were
electrophoresed and transferred onto a nylon membrane (immobilon-Ny+,
Millipore, Bedford, MA). The membrane was then hybridized with insulin receptor
cDNA (b). Skeletal muscle cells were treated without (C) or with palmitate and
then incubated with insulin for 30 min. On termination of incubations, cells
were lysed by sonication and 50µg protein from each cell lysate was resolved in
SDS-PAGE and then subjected to Western blot analysis with anti insulin receptor
β (IRβ) antibody for determination of the IRβ protein content (c).
a) b)
a)
b)
c)
gene and semiquantitative PCR data showed a significant
decrease in IR mRNA in palmitate treated muscle cells
(Fig.2a). To have additional data on IR gene expression
we performed Northern hybridization by using rat insulin
receptor cDNA as a radiolabelled probe. Palmitate
incubations strongly reduced IR mRNA expression as
compared to control (Fig.2b). Western blot analysis shows
that the protein level also decreases consequently in
palmitate incubated cells as compared to the control (Fig
2c). These results suggest that fatty acid -induced insulin
resistance is related to reduced expression of IR gene.
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Fig. 3. Control or palmitate incubated skeletal muscles were
treated with insulin for 30 min, lysed by sonication in lysis
buffer and centrifuged for 10 min at 10,000 g. 200 µg supernatant
protein from control and treated cells was incubated overnight
at 4°C with 2 µg IRβ antibody. The antigen-antibody complex
was pelleted with protein A-agarose, immunoprecipitated
pellets were washed thoroughly, resuspended in SDS-PAGE
sample buffer, boiled and electrophoresed. Proteins from the
gel were transferred to PVDF membrane and immunoblotted
with anti-p-Tyr antibody. C-control; I-Insulin; I+P-insulin plus
Involvment of PKC isoforms in fatty acid induced
inhibition of insulin signals
Insulin binding to the receptor results in
phosphorylation of IRβ tyrosine kinase. When solubilized
receptor preparation from control or palmitate incubated
muscle cells were allowed to form immuno-complex with
anti-IRβ antibody and subsequently probed with anti-
phosphotyrosine antibody, a significant decrease in insulin-
stimulated tyrosine phosphorylation of IRβ was observed
in the receptor preparation from palmitate incubated cells
(Fig.3a). Results indicate a correlation between palmitate-
induced inhibition of IR gene expression, insulin-IR
a)
b)
c)
complex and insulin receptor tyrosine kinase
phosphorylation. This prompted us to examine insulin-
stimulated downstream signals, which are consequently
phosphorylated following IRβ tyrosine kinase
phosphorylation. Insulin stimulated IRβ phosphorylation
follows IRS 1 tyrosine phosphorylation and that was
clearly inhibited by palmitate (Fig. 3b). A PKC isotype,
PKCδ, was implicated in IR regulation. Palmitate treated
skeletal muscle cells showed greater phosphorylation of
PKCδ as compared to insulin alone (Fig. 3c), suggesting
involvement of PKCδ in the inhibition of IRβ and IRS1
tyrosine phosphorylation. We then investigated the effect
palmitate. IRS-1 was used as a loading control (a). Skeletal
muscle cells were treated without (C) or with palmitate for 8 h.
and then incubated with insulin for 30 min. On termination of
incubations, cells were lysed by sonication and 50 µg protein
from each cell lysate was resolved in SDS-PAGE and then
subjected to Western blot analysis with phospho-specific
antibodies against pIRS1 (1:1000) (b) or pPKCδ (1:1000) (c).
IRS 1 was used as the loading control. Densitometric analysis
of immunoblots was performed by Image J software.
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Fig. 4. Skeletal muscle cells were incubated in the absence of
insulin and palmitate and that was taken as control (C). Control
cells exposed to insulin for 30 min (I) or palmitate incubated
cells for 8h and then incubated with insulin for 30 min (I+P). On
termination of incubations, cells were lysed by sonication and
50 µg protein from each cell lysate was resolved in 10% SDS-
PAGE and then subjected to Western blot analysis with
phospho-specific antibodies against pPI3 Kinase (1:1000) (a),
pPDK1 (1:1000)(b) or pAkt 1/2 (1:1000) (c) and PKCζ (d). In a
separate set of experiment immunoblotting was performed with
corresponding non-phosphorylated antibodies for PI3 kinase,
PDK1 and Akt 1/2, for PKC ζ anti IRS 1 was used as loading
control.
a)
b)
c)
of palmitate on IRS1 associated PI3 kinase
phosphorylation. Insulin-stimulated phosphorylation of PI3
kinase is expected to be inhibited by palmitate as it causes
reduction in IRS1 phosphorylation. Fig. 4a and 4b
demonstrate inhibition in insulin-stimulated phosphorylation
of PI3 kinase and PI3 kinase dependent protein kinase 1
(PDK1) by palmitate. In insulin signal transduction
pathway, PDK1 is the upstream kinase that directly
phosphorylates downstream substrates such as Akt/PKB
and PKC ζ. Insulin stimulated phosphorylation of Akt/
PKB and PKC ζ was inhibited in palmitate incubated
skeletal muscle cells (Fig. 4c and 4d). Palmitate did not
change PI3 kinase, PDK1, and Akt protein profile of
skeletal muscle cells.
Induced phosphorylation of PKC ε is related to
reduced IR gene expression
Although above description of our results clearly
indicate palmitate induced inhibition of insulin signaling
pathway and involvement of PKC δ and PKC ζ there
on, it could not suggest the possible mechanism involved
in the inhibition of IR gene expression by palmitate.
Phosphorylation of PKCε is dependent on PDK1, PKCε
becomes a substrate of PDK1 when it is membrane
bound. We had an unexpected result; palmitate incubation
of skeletal muscle cells intensified insulin stimulated
phosphorylation of PKCε. Since palmitate inhibited PDK1
phosphorylation, one would expect inhibition of PKCε by
it. In contrast, palmitate stimulated phosphorylation of
PKCε was more than what was observed with insulin
(Fig 5a), pamitate did not alter PKCε protein content.
Surprisingly, incubation of muscle cells with palmitate
alone increased PKCε phosphorylation. In searching the
possible cause for this, we found an earlier report
describing constitutive phosphorylation of PKCε by fatty
acid in a PDK1 independent way [32]. Considering this
to be a probability, we conducted a time kinetic study that
showed an interesting trend. Palmitate stimulated PKC
ε phosphorylation in a time dependent manner, increase
of phosphorylation was detected at 2h which increased
further at 6h (Fig 5b). Activation of PKC ε was inversely
related to IR gene expression, palmitate decreases IR
mRNA in a similar time dependent manner (Fig 5c).
Calphostin C, an inhibitor of PKC, blocked palmitate
induced PKC ε phosphorylation (Fig 5d). Palmitate could
not reduce IR gene expression in the presence of
calphostin C (Fig 5e). This indicates an association of
activated PKC ε with reduced IR gene expression. Fig 6
demonstrates that change in the localization of PKC ε
occurs due to phosphorylation by palmitate, at 2h
phosphorylated PKCε was detected in the plasma
membrane fraction, while at 6h most of the phosphorylated
PKCε was associated with nuclear fraction (Fig 6a).
Detection with immunofluorescent probe also showed
translocation of pPKCε from cytosol to nuclear region at
6h (Fig 6b). Hence, experiments with palmitate showed
d)
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a time dependent translocation of phosphorylated PKCε
indicating a possible involvement of PKC ε in palmitate
induced inhibition of IR gene transcription.
Discussion
Several studies suggest oversupply of lipid to
peripheral tissues is responsible for the development and
severity of insulin resistance. Patients suffering from
insulin resistance frequently display signs of abnormal lipid
metabolism, increased circulatory concentrations and
elevated deposition of lipid in skeletal muscle [9, 33]. It is
now well accepted that fatty acid opposes insulin action
but how it does so still remains unclear. We have observed
impairment of insulin binding to its receptor due to
palmitate. Our selection of palmitate as a fatty acid was
based on our experiments with different saturated and
unsaturated fatty acids (data not shown) and also earlier
reports where it was shown to be the most potential fatty
acid in impairing insulin sensitivity [34-37]. It was not
clear to us how palmitate incubation could inhibit insulin
binding to IR; since there was no change in Ka while Bmax
was reduced to two-fold, a reduction in IR number
appeared to be related to this inhibition. This led us to
investigate whether this downregulation of IR number is
due to the impairment of IR gene expression causing
reduction in IR protein. Both RT-PCR data and Northern
analysis demonstrated an inhibition of IR gene expression
by palmitate. The mechanism underlying here is unknown;
Fig. 5. Skeletal muscle cells were treated without or with
palmitate for 8h and insulin was added to both control (I) and
palmitate (I+P) incubated cells. Cells without any of the
treatments were taken as control (C). On termination of
incubations, cells were lysed by sonication and 50 µg protein
from each cell lysate was resolved in 10% SDS-PAGE and
then subjected to Western blot analysis with anti PKCε or
anti pPKCε antibodies (1:1000) (a). A time kinetic study was
carried out by incubating cells with palmitate at different time
periods. At the end of each incubation, cells were similarly
lysed, subjected to SDS PAGE and was immunoblotted
against anti pPKCε antibody (anti Goat, 1:1000) (b). A Northern
blot analysis showing time dependent decrease of IR mRNA
(c). Western blot of pPKC ε demonstrating inhibition of
palmitate stimulated phosphorylation of PKC ε by Calphostin
C (100nM) (d). Northern blot shows unaltered IR mRNA level
in the presence of Calphostin C (e).
a)
b)
c)
d)
e)
however our study on PKC isoforms indicates a possible
pathway.
The insulin receptor is a heterotetrameric tyrosine
kinase receptor, binding of insulin activates its kinase and
that phosphorylates intracellular docking proteins IRS1,
IRS2. These docking molecules then recruit and stimulate
various effector enzymes [34, 38]. IRS proteins
phosphorylate PI3Kinase, which in turn converts
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Fig. 6. Translocation of palmitate induced pPKCε was
observed at different time periods (2h, 4h, 6h).  Plasma
membrane (pm) and nuclear fractions (nu) from control (C) or
palmitate treated cells were obtained by following the
procedures described by Frevert and Kahn, 1996 [45]. Proteins
were separated by 10% SDS PAGE and then immunoblotted
with anti pPKCε antibody (a). Distribution of palmitate induced
phosphorylated PKCε in skeletal muscle cells as revealed by
fluorescence microscopy. Skeletal muscle cells were seeded on
to collagen-coated coverslips and incubated without (C) or
phosphoinositides to phosphatidylinositol 3,4,5-
trisphosphate that recruits PDK1 and PDK1 dependent
cytosolic Akt/protein kinase B (PKB) to the plasma
membrane. PDK1 promotes Akt/PKB activation by
facilitating phosphorylation of its regulatory domains [39].
Activated Akt/PKB effected translocation of Glucose
transporter 4 (Glut4) to the cell surface membrane [40].
We have found an inhibition of IRβ tyrosine
phosphorylation in palmitate incubated muscle cells. This
is expected as palmitate-inhibited IR gene expression will
decrease the amount of Insulin-IR complex and that will
reduce IRβ tyrosine phosphorylation. Moreover, we
tracked every step of insulin signaling starting from the
inhibition of IR to IRS1, PI3 kinase, PDK1 and Akt/PKB
phosphorylations by palmitate so that the critical point in
fatty acid induced impairment of insulin sensitivity could
be identified. From our observations, inhibition of IR gene
expression appears to be the most important point.
The molecular mechanisms of insulin resistance are
indeed very complex, on the cellular level insulin resistance
may occur at multiple steps of the insulin-signaling
pathway. Among the most important candidates, recent
studies implicate PKC isoforms as major players. These
reports focused on the role of nPKCs, PKC δ, PKC θ
and PKC ε in fatty acid-induced insulin resistance [11,
20, 25]. nPKCs are found to be activated in muscles from
hyperinsulinemic and hyperglycemic humans and rats [41,
42] suggesting their involvement in the impairment of
with palmitate at different time periods, control incubation
contained BSA as vehicle. After fixation with paraformaldehyde
they were permeabilized in phosphate-buffered saline
containing 0.1% Triton X-100 and 1% BSA followed by
incubation with anti-PKCε primary antibody (1:100) and
fluorescein isothiocyanate (FITC) conjugated secondary
antibody (1:100) the coverslips were mounted in glycerol/PBS
and viewed under a fluorescence microscope (b). Bars
correspond to 10 µm.
a)
b)
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insulin sensitivity. Consistent with these studies is the
observation that PKC δ mediated inhibition of IR kinase-
catalyzed IRS1 tyrosine phosphorylation occurs as a
consequence of direct Ser/Thr phosphorylation of IRS1
by PKC δ [20].  PKC δ has also been implicated in the
internalization of IR thus attenuating insulin-induced
tyrosine phosphorylation of IR [43]. Our time kinetic data
on PKCδ phosphorylation and IR mRNA expression does
not indicate its link to fatty acid induced IR gene
downregulation. Palmitate induced inhibition of IR gene
expression has been detected at 2 h which further
decreased at 4h and 6h, whereas inhibition of PKC δ
could only be detected at 6 h and not earlier. This indicates
that PKC δ is not involved in the palmitate induced
downregulation of IR gene expression. On the other hand,
PKC δ here may be involved in the inhibition of IR kinase
activity as observed by Greene et al [20] or internalization
of IR as shown by Braiman et al [43]. One of the atypical
PKCs, PKC ζ has been shown to be activated by insulin
through PI3 kinase and PDK1 dependent pathway [44].
The association between PDK1 and PKC ζ appears to
be very close and there is extensive cross talk between
them [45, 46]. We have found that inhibition of PDK1
phosphorylation is reflected on reduced PKC ζ activity
suggesting close association of these kinases in the PI3
kinase-signaling pathway.
The novel PKCε isotype has recently been shown
to be linked to insulin signaling pathway. Activation loop
of PKCε is directly phosphorylated by PDK1 and
therefore it is another kinase in the PI3K-PDK1
dependent signaling. It has been suggested that
overexpression and chronic activation of PKCε is related
to the development of insulin resistance in animals [47].
In vitro studies indicated that PKCε plays an important
role in mediating the inhibitory effect of TNFα on insulin
signaling; TNFα is the major cause of obesity linked insulin
resistance [48, 49]. PKCε has recently been implicated
in the downregulation of IR. Ikeda et al., [47] reported
that reduction in IR numbers in the skeletal muscles of
diabetic P. obesus is correlated with the overexpression
of PKCε, this may be a possible mechanism for inducing
insulin resistance. Our investigation showed fatty acid
induced downregulation of rat skeletal muscle IR molecule
is related to inhibition of IR gene expression. We then
observed a consequent stimulation of PKCε
phosphorylation by palmitate and translocation of PKCε
from plasma membrane to nuclear region. Since
phosphorylation of PKC ε is PDK1 dependent, we were
puzzled to find inhibition of PDK1 phosphorylation by
palmitate but remarkable increase in PKC ε
phosphorylation at the same time. A report by Cenni et al
[32] cleared our confusion. They demonstrated that
myristoylation of PKCε resulted constitutive
phosphorylation at Thr 566 and Ser 729 in the kinase
domain required for PKCε activity. This phosphorylation
was independent of PDK1. Palmitoylation of PKB
similarly increased its activity, which could not be
stimulated further by growth factors [50]. In the same
way palmitoylation in our investigation probably caused
constitutive phosphorylation of PKCε effecting its
translocation to nuclear region. Mobilization of
fluorescence-tagged pPKCε also indicated the same.
These findings suggest a relationship between PKCε and
IR mRNA reduction. A similar kind of observation has
been made by Ikeda et al. [47], they found a significant
inverse correlation between insulin binding to IR and
PKCε expression. Role of PKCε in regulating LDL
receptor gene transcription has recently been shown in
human hepatoma cell line [51]. We have observed that
palmitate activation of PKC ε occurs at 2h that increased
substantially at 6h which is inversely related to IR gene
transcription, as considerable inhibition of IR mRNA could
be observed at 6 h by palmitate. Moreover, Calphostin C
inhibition of palmitate stimulated PKCε phosphorylation
is coincided with the withdrawal of IR mRNA inhibition.
These data therefore indicate an association of PKCε in
palmitate induced downregulation of IR gene expression.
However, underlying mechanism of this is not known.
There is a possibility that activated PKCε phosphorylates
HMGA1 (a high mobility group protein); an integral
molecule of IR transcription factor complex required for
IR gene transcription [52]. It has been shown that
phosphorylation blocks HMGA1 mobilization to promoter
region of the gene [53]. Moreover, inhibition of HMGA1
migration by PKC was reported earlier [54, 55]. Hence,
from previous reports along with our present observations,
it appears reasonable to interpret that translocation of
palmitate activated PKCε to nuclear region might be
affecting integration of IR transcription factors due to
inhibition of HMGA1 mobilization. Further investigation
is required to explain the mechanism involved in IR gene
transcription by PKC ε. Present observations suggest
one of the possible pathways in fatty acid induced insulin
resistance.
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